An inverter/controller subsystem optimized for photovoltaic applications

Conversion of solar array dc power to ac power stimulated the specification, design, and simulation testing of an inverter/controller subsystem tailored to the photovoltaic power source characteristics. Optimization of the inverter/controller design is discussed as part of an overall photovoltaic power system designed for maximum energy extraction from the solar array. The special design requirements for the inverter/ controller include: a power system controller (PSC) to control continuously the solar array operating point at the maximum power level based on variable solar insolation and cell temperatures; and an inverter designed for high efficiency at rated load and low losses at light loadings to conserve energy

Dynamic analysis of a photovoltaic power system with battery storage capability

A photovolataic power system with a battery storage capability is analyzed. A dual battery current control concept is proposed, which enables the battery to either supply or accept power depending upon system environment and load conditions. A simulation of the power system, including the battery current control, is developed and evaluated. The evaulation demonstrate the visbility of the battery control concept of switch the battery from a charge to discharge mode and back as required by load and environmental conditions. An acceptable system operation is demonstrated over the entire insolation range. Additionally, system sensitivity, bandwidth, and damping characteristics of the battery control are shown to be acceptable for a projected hardware implementation

Performance and stability analysis of a photovoltaic power system

The performance and stability characteristics of a 10 kVA photovoltaic power system are studied using linear Bode analysis and a nonlinear analog simulation. Power conversion efficiencies, system stability, and system transient performance results are given for system operation at various levels of solar insolation. Additionally, system operation and the modeling of system components for the purpose of computer simulation are described

Resource utilization among informal caregiver of lung cancer patients undergoing treatment

The objective of this study is to explore patient and caregiver factors that shape the use of available resources to support caregiving for lung cancer patients undergoing treatment. A mixed-method study was conducted at one regional cancer centre within the Province of Ontario, Canada, using concurrent triangulation design. Adult patients with lung cancer (n=46) and their caregivers (n=42) (37 patient-caregiver dyads) were invited to complete a one-time study survey. Informal caregivers (n=20) also participated in a one-time semi-structured interview. Descriptive statistics and Pearson’s correlation were used to examine patterns of resource utilization and associations among study variables. Content analysis was conducted to analyse data from interviews. Informal caregivers demonstrated low overall resource utilization. Education materials and homecare support were the most frequently used but perceived as minimally helpful. Homecare support was associated with negative overall experience. Least used resources included paid help, caregiver support groups and volunteer drivers but volunteer drivers were associated with less caregiver burden. Qualitative analysis revealed three themes (1) emotional labour of caregiving and respite from known contacts, (2) perception of formal resources as inappropriate for non-medical needs and (3) financial needs and role conflicts remain to be overcome. Informal caregivers are most likely to turn to known existing social networks for support as a result of accessibility and convenience, which are central to addressing most caregiver needs except for financial needs and role conflict. Future research should aim to remove barriers to resource utilization and strengthen existing support and resources. Experience Framework This article is associated with the Patient, Family & Community Engagement lens of The Beryl Institute Experience Framework (https://www.theberylinstitute.org/ExperienceFramework). Access other PXJ articles related to this lens. Access other resources related to this lens

Fractional Loop Group and Twisted K-Theory

We study the structure of abelian extensions of the group $L_qG$ of $q$-differentiable loops (in the Sobolev sense), generalizing from the case of central extension of the smooth loop group. This is motivated by the aim of understanding the problems with current algebras in higher dimensions. Highest weight modules are constructed for the Lie algebra. The construction is extended to the current algebra of supersymmetric Wess-Zumino-Witten model. An application to the twisted K-theory on $G$ is discussed.Comment: Final version in Commun. Math. Phy

SNM measurement uncertainites: potential impacts for materials disposition

A discussion of nuclear material measurement uncertainties and impacts to the Materials Disposition (MD) Program is presented. Many of the options under consideration by the disposition program present new measurement challenges include significant material processing throughputs, a variety of material forms, unique waste streams, and difficult-to-measure matrices. There are also some questions regarding the ability to achieve International Atomic Energy Agency (IAEA) verification requirements and to achieve measurement uncertainties that are small enough to meet the IAEA loss detection goals. We present a detailed formalism for determining the measurement error for nondestructive assay systems applied to the MD Program, which is an essential component for planning the safeguards and security of these systems

Optical Fiber High Temperature Sensor Instrumentation for Energy Intensive Industries

This report summarizes technical progress during the program “Optical Fiber High Temperature Sensor Instrumentation for Energy Intensive Industries”, performed by the Center for Photonics Technology of the Bradley Department of Electrical and Computer Engineering at Virginia Tech. The objective of this program was to use technology recently invented at Virginia Tech to develop and demonstrate the application of self-calibrating optical fiber temperature and pressure sensors to several key energy-intensive industries where conventional, commercially available sensors exhibit greatly abbreviated lifetimes due primarily to environmental degradation. A number of significant technologies were developed under this program, including • a laser bonded silica high temperature fiber sensor with a high temperature capability up to 700°C and a frequency response up to 150 kHz, • the world’s smallest fiber Fabry-Perot high temperature pressure sensor (125 x 20 μm) with 700°C capability, • UV-induced intrinsic Fabry-Perot interferometric sensors for distributed measurement, • a single crystal sapphire fiber-based sensor with a temperature capability up to 1600°C. These technologies have been well demonstrated and laboratory tested. Our work plan included conducting major field tests of these technologies at EPRI, Corning, Pratt & Whitney, and Global Energy; field validation of the technology is critical to ensuring its usefulness to U.S. industries. Unfortunately, due to budget cuts, DOE was unable to follow through with its funding commitment to support Energy Efficiency Science Initiative projects and this final phase was eliminated

Schwinger Terms and Cohomology of Pseudodifferential Operators

We study the cohomology of the Schwinger term arising in second quantization of the class of observables belonging to the restricted general linear algebra. We prove that, for all pseudodifferential operators in 3+1 dimensions of this type, the Schwinger term is equivalent to the ``twisted'' Radul cocycle, a modified version of the Radul cocycle arising in non-commutative differential geometry. In the process we also show how the ordinary Radul cocycle for any pair of pseudodifferential operators in any dimension can be written as the phase space integral of the star commutator of their symbols projected to the appropriate asymptotic component.Comment: 19 pages, plain te

Factors affecting the choice of first-line therapy in Parkinson's disease patients in Wales: A population-based study

First line treatment for Parkinson’s disease (PD) is typically either L-dopa or a non-ergot dopamine agonist (DA). However, the options for the treatment of motor symptoms in PD patients have increased in the last thirty years, which have seen several new classes of PD medications introduced onto the market. The purpose of this study is to examine the changes in first line therapy of newly diagnosed Parkinson’s patients between 2000 and 2016 in Wales. A population-based study evaluated data from the Secure Anonymised Information Linkage (SAIL) Databank of residents in Wales, aged 40 years or older, newly treated with PD medications between 2000 and 2016. The data was compared across three intervals: 2000–2005, 2006–2011 and 2012–2016. Patients were classified by age at diagnosis into young: 40–60 years; mid, 61–80 years; and older >80 years. Logistic regression was undertaken to determine the predictors of PD medication prescribing. For the whole study period, the profiles of 9142 newly diagnosed PD patients were analysed. L-dopa was the most common first line therapy (80.6%), followed by non-ergot DAs (12.9%) and monoamine oxidase B (MAO-B) inhibitors (7.9%). Odds of L-dopa prescribing were greater in patients >80 years (OR = 20.46 95%CI: 16.25–25.76) and in the period 2012–2016 (OR = 1.98 95% CI: 1.70–2.29). Prescribing of non-ergot DAs significantly declined in 2012–2016 (OR = 0.42 95% CI: 0.35–0.49). Additional factors influencing first line therapy were deprivation, presence of diabetes and prior use of antidepressants. For example, PD patients residing in the least deprived area were less likely to be prescribed L-dopa compared to patients residing in the most deprived area (OR = 0.77 95% CI: 0.65–0.93). First line therapy in PD in Wales has undergone a significant switch towards L-dopa over the last 16 years. The data indicates reasonable compliance with guidelines on efficacy and safety issues related to Parkinson’s medications